FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmaceutics and concerns the method for modulation of cell adhesion in a cancer patient by introducing to the patient the compound of formula 
(II) and measuring count of at least one inducible molecules of cell adhesion, molecule of vascular cell adhesion or a molecule of endothelial leukocyte adhesion.
EFFECT: method can ensure prevention of metastatic and other diseases mediated by molecules of cell adhesion.
30 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZOISOXAZOLES, PYRAZOLOPYRIDINES, ISOTHIAZOLOPYRIDINES, PREPARING AND USING THEM | 2006 |
|
RU2450003C2 |
| PYRROLIDINE AND PIPERIDINE COMPOUNDS | 2020 |
|
RU2803455C1 |
| CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
| PYRAZOLOPYRIMIDINE DERIVATIVES AS A KINASE INHIBITOR | 2017 |
|
RU2714206C1 |
| METHODS FOR TREATMENT OF MALIGNANT TUMOR USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITY | 2016 |
|
RU2765154C2 |
| INDAZOLES, BENTOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES AND SYNTHESIS AND USE THEREOF | 2005 |
|
RU2417225C2 |
| SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR TREATING VESTIBULAR DISORDERS | 2009 |
|
RU2589846C2 |
| DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS | 2003 |
|
RU2314306C2 |
| BENZYLPIPERIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARATION THEREOF | 1995 |
|
RU2160259C2 |
| METHODS FOR TREATMENT OF MULTIPLE SCLEROSIS, USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK-INHIBITING ACTIVITY | 2016 |
|
RU2779287C2 |
